PD-1 Limits IL-2 Production and Thymic Regulatory T Cell Development
ImmunoHorizons · 01.03.2024 · 8 (3) · 281-294
DOI: 10.4049/immunohorizons.2300079 ↗Kurz gefasst
Fachartikel in der Zeitschrift ImmunoHorizons, online erschienen am 29.03.2024. Verfasst von Breanna Caruso und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, OR. Hauptthemen laut MEDLINE: Interleukin-2, Programmed Cell Death 1 Receptor, T-Lymphocytes, Regulatory, Thymus Gland. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, CSRD VA, National Science Foundation.
Abstract (Originalsprache)
Inhibitory proteins, such as programmed cell death protein 1 (PD-1), have been studied extensively in peripheral T cell responses to foreign Ags, self-Ags, and neoantigens. Notably, these proteins are first expressed during T cell development in the thymus. Reports suggest that PD-1 limits regulatory T cell (Treg) development, but the mechanism by which PD-1 exerts this function remains unknown. The present study expands the evaluation of murine PD-1 and its ligands in the thymus, demonstrating that some of the highest expressers of PD-1 and programmed death-ligand 1 are agonist selected cells. Surprisingly, we reveal a selective role for PD-1 in regulating the developmental niche only for Tregs because other agonist selected cell populations, such as NK T cells, remain unchanged. We also ruled out PD-1 as a regulator of proliferation or cell death of agonist selected Tregs and further demonstrated that PD-1–deficient Tregs have reduced TCR signaling. Unexpectedly, the data suggest that PD-1–deficient thymocytes produce elevated levels of IL-2, a Treg niche–limiting cytokine. Collectively, these data suggest a novel role for PD-1 in regulating IL-2 production and the concurrent agonist selection of murine thymic Tregs. This observation has implications for the use of checkpoint blockade in the context of cancer and infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, OR.
- Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR.
- Knight Cancer Institute, Oregon Health and Science University, Portland, OR.
- Department of Radiation Medicine, Oregon Health and Science University, Portland, OR.
- Veterans Affairs Portland Health Care System, Portland,OR.
ORCID-Profile: Breanna Caruso, Amy E Moran
Förderung
- NCI NIH HHS
- CSRD VA
- National Science Foundation
- National Cancer Institute
- National Institutes of Health
- OHSU Foundation
Zitieren
APA
Caruso, B., Weeder, B. R., Thompson, R. F., & Moran, A. E. (2024). PD-1 Limits IL-2 Production and Thymic Regulatory T Cell Development. ImmunoHorizons, 8(3), 281-294. https://doi.org/10.4049/immunohorizons.2300079
Vancouver
Caruso B, Weeder BR, Thompson RF, Moran AE. PD-1 Limits IL-2 Production and Thymic Regulatory T Cell Development. ImmunoHorizons. 2024;8(3):281-294. doi:10.4049/immunohorizons.2300079
BibTeX
@article{Caruso2024,
author = {Caruso, Breanna and Weeder, Benjamin R and Thompson, Reid F and Moran, Amy E},
title = {PD-1 Limits IL-2 Production and Thymic Regulatory T Cell Development},
journal = {ImmunoHorizons},
year = {2024},
volume = {8},
number = {3},
pages = {281--294},
doi = {10.4049/immunohorizons.2300079}
}
EUVIMED